Integra Lifesciences Holdings Corp

자세한 내용은 Integra Lifesciences Holdings Corp 회사

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

회사 정보

종목 코드 IART

회사 이름Integra Lifesciences Holdings Corp

상장일Aug 16, 1995

CEOMs. Mojdeh Poul

직원 수4396

유형Ordinary Share

회계 연도 종료Aug 16

주소1100 Campus Road

도시PRINCETON

증권 거래소NASDAQ Global Select Consolidated

국가United States of America

우편 번호08540

전화16092750500

웹사이트https://www.integralife.com/

종목 코드 IART

상장일Aug 16, 1995

CEOMs. Mojdeh Poul

회사 임원

이름

이름/직위

직위

주식 보유

변동

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.79M

+1.82%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

Mr. Harvinder Singh

Executive Vice President, President - International Business

13.25K

+1024.00%

Ms. Mojdeh Poul

President, Chief Executive Officer, Director

--

Ms. Shaundra D. Clay

Independent Director

--

Mr. Chris Ward

IR Contact Officer

--

이름

이름/직위

직위

주식 보유

변동

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.79M

+1.82%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Neurosurgery

190.91M

49.89%

Wound Reconstruction and Care

74.78M

19.54%

Instruments

50.95M

13.31%

ENT

38.80M

10.14%

Private Label

27.21M

7.11%

지역별USD

이름

수익

비율

United States

282.22M

73.75%

Asia Pacific

45.10M

11.79%

Europe

35.33M

9.23%

Rest of World

20.00M

5.23%

사업별

지역별

사업별USD

이름

수익

비율

Neurosurgery

190.91M

49.89%

Wound Reconstruction and Care

74.78M

19.54%

Instruments

50.95M

13.31%

ENT

38.80M

10.14%

Private Label

27.21M

7.11%

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

BlackRock Institutional Trust Company, N.A.

12.52%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.59%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.03%

Other

52.49%

주주

비율

BlackRock Institutional Trust Company, N.A.

12.52%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.59%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.03%

Other

52.49%

주주 유형

주주

비율

Investment Advisor

41.95%

Investment Advisor/Hedge Fund

39.09%

Hedge Fund

15.00%

Corporation

10.96%

Individual Investor

3.45%

Research Firm

1.90%

Pension Fund

1.10%

Sovereign Wealth Fund

0.62%

Bank and Trust

0.45%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

598

89.03M

114.56%

-18.85M

2025Q1

635

87.01M

111.97%

-18.30M

2024Q4

636

81.93M

106.10%

-20.27M

2024Q3

638

82.93M

106.93%

-12.58M

2024Q2

628

84.82M

107.92%

-1.75M

2024Q1

613

79.36M

101.18%

-3.69M

2023Q4

597

79.81M

101.26%

-5.74M

2023Q3

592

81.88M

100.31%

-3.94M

2023Q2

587

82.30M

100.29%

-6.57M

2023Q1

579

85.87M

104.63%

-5.43M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

BlackRock Institutional Trust Company, N.A.

9.75M

12.55%

-341.75K

-3.38%

Mar 31, 2025

TRU ST Partnership, L.P.

8.52M

10.96%

--

Feb 28, 2025

The Vanguard Group, Inc.

7.47M

9.61%

-66.65K

-0.88%

Mar 31, 2025

Rubric Capital Management LP

4.64M

5.98%

+2.03M

+77.35%

Mar 31, 2025

Fuller & Thaler Asset Management Inc.

3.92M

5.05%

-9.76K

-0.25%

Mar 31, 2025

Invesco Advisers, Inc.

3.13M

4.02%

+1.36M

+77.42%

Mar 31, 2025

Wellington Management Company, LLP

2.77M

3.56%

+259.99K

+10.37%

Mar 31, 2025

State Street Global Advisors (US)

2.75M

3.54%

-105.48K

-3.70%

Mar 31, 2025

Boston Management and Research

2.74M

3.53%

--

Mar 31, 2025

AllianceBernstein L.P.

2.71M

3.48%

+128.04K

+4.97%

Mar 31, 2025

12.230USD

Integra Lifesciences Holdings Corp

12.230

개요

회사

금융